pharmaphorum

DECEMBER 15, 2021

Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon. But the difference between them is not like the choice between “agreeing” and “aligning” or “getting together later” and “taking this offline.” Going from the vital activity of patient engagement to the more encompassing state of patient centricity requires big steps in the evolution of new-drug discovery, development, and delivery.

Communication 140

Communication Hospitals 140

Outsourcing Pharma

DECEMBER 15, 2021

The artificial intelligence-driven drug discovery company has dosed its first healthy volunteer in a trial for a candidate to treat idiopathic pulmonary fibrosis.

141

141

pharmaphorum

DECEMBER 15, 2021

Incyte could be a few month away from a second FDA approval for its Opzelura cream that would make it the first medical treatment to re-pigment the skin of people with vitiligo. The FDA has kicked off a priority review of Opzelura (ruxolitinib), a JAK1/JAK2 inhibitor it approved to treat atopic dermatitis in September, and aims to decide on the vitiligo indication by 18 April next year.

FDA 109

FDA 109

Outsourcing Pharma

DECEMBER 15, 2021

The Parkinsonâs Progression Markers Initiative, built using Evidation Healthâs research platform, aims to triple enrollment and recruit online participants.

125

125

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

DECEMBER 15, 2021

Northwell Health, American Academy of Family Physicians and Athenahealth join digital health equity pledge. agliadkovskaya. Wed, 12/15/2021 - 12:21.

116

116

pharmaphorum

DECEMBER 15, 2021

Bristol-Myers Squibb’s rheumatoid arthritis drug Orencia has been approved by the FDA to prevent graft versus host disease (GvHD), a serious complication of haematopoietic stem cell transplant (HSCT) used to treat leukaemias and other blood cancers. Orencia (abatacept) becomes the first drug to be approved to prevent GvHD , a condition in which donor immune cells attack tissues in the patient receiving an HSCT, commonly known as a bone marrow transplant.

FDA 104

FDA Immunization 104

pharmaphorum

DECEMBER 15, 2021

Biogen has made a $15 million investment in digital health company TheraPanacea, which will go towards a project to find digital health tools aimed at neurological diseases. There’s another $41 million in possible future payments if the partnership progresses as planned, said Biogen, which is getting exclusive rights to TheraPancea’s machine learning and artificial intelligence platforms in neuroscience.

Patient Care 69

Patient Care 69

Fierce Healthcare

DECEMBER 15, 2021

CMS actuaries: Healthcare expenditures spiked 9.7% in 2020 amid COVID-19 response. pminemyer. Wed, 12/15/2021 - 16:28.

128

128

pharmaphorum

DECEMBER 15, 2021

Patients in Wales with a rare disease that causes epilepsy will be the first in the UK to get access to GW Pharma’s cannabis-based medicine Epidyolex, after the drug was cleared for use by the NHS. Epidyolex (cannabidiol) can now be prescribed in Wales as a treatment for seizures associated with tuberous sclerosis complex (TSC), adding to its earlier approvals for Lennox-Gastaut syndrome (LGS) and Dravet syndrome, two other forms of epilepsy.

FDA 59

FDA 59

Fierce Healthcare

DECEMBER 15, 2021

Moody's: Outlook stable for insurers in 2022, but COVID-19's effects could linger. pminemyer. Wed, 12/15/2021 - 13:27.

Insurance 124

Insurance 124

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

indispensable health

DECEMBER 15, 2021

An Interview With Paula Styer, Licensed Pharmacy Technician (LPhT). What Is Your Name and Job Title? Well, my name is Paula Styler and I am a pharmacy technician. I have been a pharmacy technician since 2008. When Did You Become Interested in Pharmacy? I had been working in photography for a very long time, and the studio I worked for closed. I was unemployed for about a year and a half to two years.

Compounding 52

Compounding Hospitals Packaging Chemotherapy 52

Fierce Healthcare

DECEMBER 15, 2021

Industry Voices—How prior authorization can disrupt medically necessary care. pminemyer. Wed, 12/15/2021 - 13:40.

122

122

pharmaphorum

DECEMBER 15, 2021

Apellis Pharma and partner Sobi have won EU approval for their paroxysmal nocturnal haemoglobinuria (PNH) drug pegcetacoplan in Europe, with a more restricted label than in the US. The European Commission has cleared the complement C3 inhibitor as Aspaveli for the treatment of adults with PNH who are anaemic, but only after they have been treated for at least three months with a C5 inhibitor.

Labelling 52

Labelling FDA Immunization 52

Fierce Healthcare

DECEMBER 15, 2021

CMMI seeking safety-net providers for new wave of models that focus on health equity. rking. Wed, 12/15/2021 - 16:52.

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Med Ed 101

DECEMBER 15, 2021

In this case of a 72-year-old male, I want to discuss levofloxacin risks as there can be numerous. He currently lives in an assisted living. He has a past medical history of arrhythmia, depression, GERD, hypertension and gout. He was recently diagnosed with community-acquired pneumonia and his physician has prescribed levofloxacin. His current medications besides […].

Assisted Living 40

Assisted Living 40

Fierce Healthcare

DECEMBER 15, 2021

LAN survey: 40% of health payments tied to alternative payment models in 2020. rking. Wed, 12/15/2021 - 15:21.

119

119

Pharma Times

DECEMBER 15, 2021

The DIOSvax technology produced by the University of Southampton aims to predict how the virus could mutate.

Vaccines 40

Vaccines 40

Fierce Healthcare

DECEMBER 15, 2021

Wheel teams up with GoodRx to integrate medication pricing information into its virtual care platform. hlandi. Wed, 12/15/2021 - 07:12.

105

105

Pharma Times

DECEMBER 15, 2021

Omicron has been the latest variant to test the effectiveness of COVID-19 vaccines.

Vaccines 43

Vaccines 43

Fierce Healthcare

DECEMBER 15, 2021

UnitedHealth pushes back deadline for Change Healthcare acquisition to April. pminemyer. Wed, 12/15/2021 - 18:30.

111

111

pharmaphorum

DECEMBER 15, 2021

Robert Califf looks set to take a second term as FDA commissioner after navigating a relatively placid two-hour confirmation hearing in the US Senate, with just a few ripples of discontent over issues like opioid medicines and his ties to the pharma industry. President Joe Biden’s nominated candidate for the post told lawmakers that he would have three main objectives if he gets the job, including shoring up the US’s emergency preparedness, modernising and reforming the FDA, and pati

FDA 52

FDA Communication 52

Fierce Healthcare

DECEMBER 15, 2021

Humana, Centene sue pharma companies over alleged scheme to squash HIV drug competition. pminemyer. Wed, 12/15/2021 - 10:52.

105

105

Fierce Healthcare

DECEMBER 15, 2021

Big data startup Innovaccer nabs $150M, catapults to $3.2B valuation. rtorrence. Wed, 12/15/2021 - 10:50.

93

93